|
Metastatic Gastric Cancer with Her2 Expression |
07/19/2024 - 8:00am to 9:00am EDT |
|
CD20 X CD3 Bispecifics-Redefining Treatment for Patients with R/R DLBCL/LBCL |
07/26/2024 - 8:00am to 9:00am EDT |
|
A Case of Blast Phase CML (BP-CML) |
09/06/2024 - 8:00am to 9:00am EDT |
|
Screening for Social Risk Factors and Addressing Needs Among Cancer Survivors: Lessons Learned from the Building Equal Access Together in Cancer (BEAT-C) Study |
09/13/2024 - 8:00am to 9:00am EDT |
|
Sickle Cell Disease - Chronic Management |
09/20/2024 - 8:00am to 9:00am EDT |
|
Targeting Resistance in EGFRm NSCLC with HER 3-Directed ADCs |
09/27/2024 - 8:00am to 9:00am EDT |
|
Multiple Myeloma and Its First LIne Therapies |
10/04/2024 - 8:00am to 9:00am EDT |
|
Rethinking and Refining Endometrial Cancer Care in the Modern Age of Precision Medicine: How to Translate Clinical Evidence Into Meaningful Improvements for Patients |
10/11/2024 - 8:00am to 9:00am EDT |
|
Adjuvant Treatment for Hormonal Positive Early Breast Cancer |
10/18/2024 - 8:00am to 9:00am EDT |
|
Targeting Transposable Elements to Reverse Cancer Immune Evasion |
10/25/2024 - 8:00am to 9:00am EDT |